Elevated fibroblast growth factor 23 in women with malignant ovarian tumors

To determine whether fibroblast growth factor 23 (FGF23) concentrations are altered in women with ovarian cancers in which FGF physiology is known to be abnormal. Between May 2002 and September 2003 at the Mayo Clinic in Rochester, Minn, plasma or serum FGF23 concentrations were measured in 39 healt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mayo Clinic proceedings 2005-06, Vol.80 (6), p.745-751
Hauptverfasser:	TEBBEN, Peter J, KALLI, Kimberly R, CLIBY, William A, HARTMANN, Lynn C, GRANDE, Joseph P, SINGH, Ravinder J, KUMAR, Rajiv
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences Biomarkers, Tumor - blood Cystadenocarcinoma, Serous - blood Cystadenocarcinoma, Serous - pathology Enzyme-Linked Immunosorbent Assay Female Female genital diseases Fibroblast Growth Factors - blood General aspects Gynecology. Andrology. Obstetrics Humans Immunohistochemistry Medical sciences Middle Aged Neoplasm Staging - methods Ovarian Neoplasms - blood Ovarian Neoplasms - pathology Retrospective Studies Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!